OPTI-AML Challenges Fixed Venetoclax Shortening
The prospective randomized OPTI-AML study did not establish that a 14-day venetoclax schedule was noninferior to 28 days when combined with azacitidine in newly diagnosed patients aged 60 years or older. Complete-remission rates were…
